Literature DB >> 9649361

Plasma-pooling methods to increase throughput for in vivo pharmacokinetic screening.

C E Hop1, Z Wang, Q Chen, G Kwei.   

Abstract

Mesh：

Year:  1998        PMID： 9649361     DOI： 10.1021/js970486q

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  24 in total

Review 1.  Mass spectrometry innovations in drug discovery and development.

Authors:  D I Papac; Z Shahrokh
Journal:  Pharm Res       Date:  2001-02       Impact factor: 4.200

2.  Pharmacokinetic/pharmacodynamic integration in drug development and dosage-regimen optimization for veterinary medicine.

Authors:  Pierre-Louis Toutain
Journal:  AAPS PharmSci       Date:  2002

3.  Assessment of the absorption, metabolism and absolute bioavailability of maraviroc in healthy male subjects.

Authors:  Samantha Abel; Deborah Russell; Lyndsey A Whitlock; Caroline E Ridgway; Angus N R Nedderman; Donald K Walker
Journal:  Br J Clin Pharmacol       Date:  2008-04       Impact factor: 4.335

4.  Rapid in vivo oral screening in rats: reliability, acceptance criteria, and filtering efficiency.

Authors:  Hong Mei; Walter Korfmacher; Richard Morrison
Journal:  AAPS J       Date:  2006-07-28       Impact factor: 4.009

5.  Dog colonoscopy model for predicting human colon absorption.

Authors:  Steven C Sutton; Loreen A Evans; Jay H Fortner; Jennifer M McCarthy; Kathy Sweeney
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.200

6.  Pharmacokinetics and tolerability of SRT2104, a first-in-class small molecule activator of SIRT1, after single and repeated oral administration in man.

Authors:  Ethan Hoffmann; Jeff Wald; Siva Lavu; John Roberts; Claire Beaumont; Jon Haddad; Peter Elliott; Christoph Westphal; Eric Jacobson
Journal:  Br J Clin Pharmacol       Date:  2013-01       Impact factor: 4.335

7.  Simultaneous analysis of multiple monoclonal antibody biotherapeutics by LC-MS/MS method in rat plasma following cassette-dosing.

Authors:  Hongyan Li; Robert Ortiz; Linh T B Tran; Hossein Salimi-Moosavi; Jennifer Malella; Christopher A James; Jean W Lee
Journal:  AAPS J       Date:  2012-12-12       Impact factor: 4.009

8.  Human absorption, distribution, metabolism and excretion properties of drug molecules: a plethora of approaches.

Authors:  Claire Beaumont; Graeme C Young; Tom Cavalier; Malcolm A Young
Journal:  Br J Clin Pharmacol       Date:  2014-12       Impact factor: 4.335

9.  Clinical significance of CYP2C19 polymorphisms on the metabolism and pharmacokinetics of 11β-hydroxysteroid dehydrogenase type-1 inhibitor BMS-823778.

Authors:  Yaofeng Cheng; Lifei Wang; Lisa Iacono; Donglu Zhang; Weiqi Chen; Jiachang Gong; William Griffith Humphreys; Jinping Gan
Journal:  Br J Clin Pharmacol       Date:  2017-10-04       Impact factor: 4.335

10.  Dose-dependent exposure and metabolism of GNE-892, a β-secretase inhibitor, in monkeys: contributions by P450, AO, and P-gp.

Authors:  Ryan Takahashi; Shuguang Ma; Qin Yue; Heasook Kim-Kang; Yijun Yi; Joseph P Lyssikatos; Kelly Regal; Kevin W Hunt; Nicholas C Kallan; Michael Siu; Cornelis E C A Hop; Xingrong Liu; S Cyrus Khojasteh
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-04-03       Impact factor: 2.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.